improve:As a factor with immunomodulatory and anti-inflammatory effects, IL-10 has been…
- User
improve:As a factor with immunomodulatory and anti-inflammatory effects, IL-10 has been continuously validated for its potential application in anti fibrosis. Our previous research showed that rapid and high-volume injection of IL-10 eukaryotic expression plasmids through the tail vein can significantly reduce CCL4 induced liver fibrosis in rats. This study provides IL-10 gene intervention in a CCL4 induced liver fibrosis mouse model, and the results support previous reports. The IL-10 gene intervention significantly alleviates liver injury, fibrosis, and improves liver function in mice, characterized by reduced infiltration of inflammatory cells in the liver, thinning of thick collagen fibers, reduction of necrotic liver cells, decreased plasma transaminase levels, and decreased hydroxyproline content in liver tissue.
- Assistant
Improved:
IL-10, known for its immunomodulatory and anti-inflammatory effects, has been extensively studied for its potential to combat fibrosis. In our previous research, we demonstrated that a rapid and high-volume injection of IL-10 eukaryotic expression plasmids, administered through the tail vein, effectively reduced CCL4-induced liver fibrosis in rats. Building on these findings, we conducted a study to investigate the impact of IL-10 gene intervention in a mouse model of CCL4-induced liver fibrosis. The results obtained in this study further corroborate the previous reports, as IL-10 gene intervention led to a significant reduction in liver injury, fibrosis, and improvement in liver function in mice. These positive outcomes were observed through various indicators, including the reduced infiltration of inflammatory cells in the liver, thinning of thick collagen fibers, decreased presence of necrotic liver cells, lower plasma transaminase levels, and a decrease in hydroxyproline content in liver tissue.
- User
IL-10, known for its immunomodulatory and anti-inflammatory effects, has been extensively studied for its potential to combat fibrosis. In our previous research, we demonstrated that a rapid and high-volume injection of IL-10 eukaryotic expression plasmids, administered through the tail vein, effectively reduced CCL4-induced liver fibrosis in rats. Building on these findings, we conducted a study to investigate the impact of IL-10 gene intervention in a mouse model of CCL4-induced liver fibrosis. The results obtained in this study further corroborate the previous reports, as IL-10 gene intervention led to a significant reduction in liver injury, fibrosis, and improvement in liver function in mice. These positive outcomes were observed through various indicators, including the reduced infiltration of inflammatory cells in the liver, thinning of thick collagen fibers, decreased presence of necrotic liver cells, lower plasma transaminase levels, and a decrease in hydroxyproline content in liver tissue.
- Assistant
Revised:
IL-10 is a factor known for its ability to modulate the immune system and reduce inflammation. It has been extensively studied for its potential application in treating fibrosis. In our previous research, we demonstrated that injecting IL-10 eukaryotic expression plasmids at a rapid and high volume, through the tail vein, effectively reduced liver fibrosis induced by CCL4 in rats.
Building on these findings, we conducted a study to assess the impact of IL-10 gene intervention in a mouse model of CCL4-induced liver fibrosis. The results of this study further support the previous reports, as IL-10 gene intervention resulted in a significant improvement in liver injury, fibrosis, and overall liver function in mice. Several indicators were used to evaluate these positive outcomes, including a decrease in inflammatory cell infiltration in the liver, thinning of collagen fibers, reduced presence of necrotic liver cells, lower levels of plasma transaminases, and a decrease in hydroxyproline content in liver tissue.
- User
The role of immune cells in liver fibrosis
- Assistant
Liver fibrosis is a complex and dynamic process characterized by the excessive accumulation of extracellular matrix (ECM) proteins, such as collagen, in response to chronic liver injury. Immune cells play a critical role in mediating the progression or resolution of liver fibrosis.
During liver injury, resident immune cells, such as Kupffer cells, reactive oxygen species (ROS), and damage-associated molecular patterns (DAMPs), are released, triggering an inflammatory response. This inflammation recruits various types of immune cells, including neutrophils, monocytes, macrophages, and lymphocytes, to the site of injury.
Neutrophils are typically the first immune cells to be recruited to the injured liver. They release inflammatory mediators and proteases, contributing to tissue damage. Monocytes are then recruited and differentiate into pro-inflammatory macrophages. These macrophages produce pro-fibrotic mediators, such as transforming growth factor-beta (TGF-β), platelet-derived growth factor (PDGF), and interleukin-1 (IL-1), which promote the activation of hepatic stellate cells (HSCs) and subsequent collagen synthesis.
Furthermore, lymphocytes, including T cells and B cells, also play a role in liver fibrosis. T cells can be classified into pro-inflammatory Th1 and Th17 subsets, which secrete cytokines like interferon gamma (IFN-γ) and IL-17, respectively, promoting inflammation and fibrosis. On the other hand, regulatory T cells (Tregs) and Th2 cells produce anti-inflammatory cytokines, such as IL-10 and IL-4, which can limit fibrogenesis.
As liver fibrosis progresses, the immune response can become dysregulated, leading to a chronic inflammatory environment. This sustained inflammation perpetuates fibrosis by promoting the activation of HSCs and inhibiting ECM degradation. Additionally, immune cells can mediate fibrosis resolution through the production of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs), which regulate ECM turnover.
Understanding the intricate interactions between immune cells and their contribution to the development and resolution of liver fibrosis is crucial in developing targeted therapies to combat this damaging condition.